Shishido, Stephanie N.
Mason, Jeremy
Kamal, Mohamed
Setayesh, Sonia Maryam
Vora, Amishi U.
Berrios, David
Rueda, Luz Yurany Moreno
Patel, Krina
Manasanch, Elisabet E.
Orlowski, Robert Z.
Kuhn, Peter
Funding for this research was provided by:
National Cancer Institute (U01CA285013, U01CA285013, U01CA285013)
USC Norris Comprehensive Cancer Center (5P30CA014089-40, 5P30CA014089-40)
Hart Family Research Fund
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (R-202312-00614, R-202312-00614, R-202312-00614)
USC Michelson Center Convergent Science Institute in Cancer
Vassiliadis Research Fund
Article History
Received: 27 February 2025
Accepted: 25 October 2025
First Online: 2 December 2025
Competing interests
: The HDSCA technology described here is licensed to Epic Sciences. P.K. has ownership in Epic Sciences. E.E.M. is an employee at GSK. All other authors declare no conflict of interest.